Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor

Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor

Yalin Xie,1 Ning Su,1 Wei Zhou,2 An Lei,1 Xiang Li,3 Weiwei Li,4 Zhan Huang,4 Wenchang Cen,1 Jinxing Hu5 1Department of Oncology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China; 2Department of Pathology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China; 3Department of...

Full description

Bibliographic Details
Main Authors: Xie Y, Su N, Zhou W, Lei A, Li X, Li W, Huang Z, Cen W, Hu J
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Cancer Management and Research
Subjects:
advanced lung adenocarcinoma
pulmonary tuberculosis
egfr mutation
egfr-tyrosine kinase inhibitors
prognosis
Online Access:https://www.dovepress.com/concomitant-pulmonary-tuberculosis-impair-survival-in-advanced-epiderm-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/concomitant-pulmonary-tuberculosis-impair-survival-in-advanced-epiderm-peer-reviewed-fulltext-article-CMAR

Similar Items